COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 179 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is 7.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,134,750 | -48.7% | 185,000 | -50.7% | 2.68% | +7.5% |
| Q2 2023 | $8,058,750 | -5.4% | 375,000 | +5.6% | 2.49% | -20.0% |
| Q1 2023 | $8,516,450 | -5.1% | 355,000 | -8.3% | 3.11% | -32.7% |
| Q4 2022 | $8,978,400 | +86.8% | 387,000 | +29.0% | 4.62% | +63.8% |
| Q3 2022 | $4,806,000 | +171.2% | 300,000 | +200.0% | 2.82% | +175.3% |
| Q2 2022 | $1,772,000 | +57.5% | 100,000 | +5.4% | 1.02% | +137.3% |
| Q2 2016 | $1,125,000 | – | 94,908 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |